h/t emertius
  COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism
  chemrxiv.org
  Abstract:
  The novel coronavirus pneumonia (COVID-19) is an infectious acute  respiratory infection caused by the novel coronavirus. The virus is a  positive-strand RNA virus with high homology to bat coronavirus. In this  study, conserved domain analysis, homology modeling, and molecular  docking were used to compare the biological roles of certain proteins of  the novel coronavirus. The results showed the ORF8 and surface  glycoprotein could bind to the porphyrin, respectively. At the same  time, orf1ab, ORF10, and ORF3a proteins could coordinate attack the heme  on the 1-beta chain of hemoglobin to dissociate the iron to form the  porphyrin. The attack will cause less and less hemoglobin that can carry  oxygen and carbon dioxide. The lung cells have extremely intense  poisoning and inflammatory due to the inability to exchange carbon  dioxide and oxygen frequently, which eventually results in  ground-glass-like lung images. The mechanism also interfered with the  normal heme anabolic pathway of the human body, is expected to result in  human disease. According to the validation analysis of these finds,  chloroquine could prevent orf1ab, ORF3a, and ORF10 to attack the heme to  form the porphyrin, and inhibit the binding of ORF8 and surface  glycoproteins to porphyrins to a certain extent, effectively relieve the  symptoms of respiratory distress. Since the ability of chloroquine to  inhibit structural proteins is not particularly obvious, the therapeutic  effect on different people may be different. Favipiravir could inhibit  the envelope protein and ORF7a protein bind to porphyrin, prevent the  virus from entering host cells, and catching free porphyrins. This paper  is only for academic discussion, the correctness needs to be confirmed  by other laboratories. Due to the side effects and allergic reactions of  drugs such as chloroquine, please consult a qualified doctor for  treatment details, and do not take the medicine yourself.
  Full paper: chemrxiv.org |